JP2022518598A5 - - Google Patents

Info

Publication number
JP2022518598A5
JP2022518598A5 JP2021544519A JP2021544519A JP2022518598A5 JP 2022518598 A5 JP2022518598 A5 JP 2022518598A5 JP 2021544519 A JP2021544519 A JP 2021544519A JP 2021544519 A JP2021544519 A JP 2021544519A JP 2022518598 A5 JP2022518598 A5 JP 2022518598A5
Authority
JP
Japan
Prior art keywords
bonds
formula
group
amino acid
hydrophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021544519A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022518598A (ja
JP7421232B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/052159 external-priority patent/WO2020157128A1/en
Publication of JP2022518598A publication Critical patent/JP2022518598A/ja
Publication of JP2022518598A5 publication Critical patent/JP2022518598A5/ja
Application granted granted Critical
Publication of JP7421232B2 publication Critical patent/JP7421232B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021544519A 2019-01-30 2020-01-29 フッ化ケイ素アクセプタ置換放射性医薬品とその前駆体 Active JP7421232B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19154636 2019-01-30
EP19154636.5 2019-01-30
PCT/EP2020/052159 WO2020157128A1 (en) 2019-01-30 2020-01-29 Silicon-fluoride acceptor substituted radiopharmaceuticals and precursors thereof

Publications (3)

Publication Number Publication Date
JP2022518598A JP2022518598A (ja) 2022-03-15
JP2022518598A5 true JP2022518598A5 (https=) 2022-12-23
JP7421232B2 JP7421232B2 (ja) 2024-01-24

Family

ID=65268875

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021544519A Active JP7421232B2 (ja) 2019-01-30 2020-01-29 フッ化ケイ素アクセプタ置換放射性医薬品とその前駆体

Country Status (7)

Country Link
US (1) US12576169B2 (https=)
EP (1) EP3917581A1 (https=)
JP (1) JP7421232B2 (https=)
CN (1) CN113677375B (https=)
AU (1) AU2020213892B2 (https=)
BR (1) BR112021012110A2 (https=)
WO (1) WO2020157128A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202005282D0 (en) 2020-04-09 2020-05-27 Blue Earth Diagnostics Ltd Pharmaceutical Formulations
WO2022018264A1 (en) * 2020-07-23 2022-01-27 Technische Universität München Silicon-containing ligand compounds
JP2024544153A (ja) 2021-11-16 2024-11-28 テクニシェ ユニバーシタット ミュンヘン 溶解した[18f]フッ化物を含む組成物の調製方法およびその方法によって得ることができる組成物
GB202207372D0 (en) 2022-05-19 2022-07-06 Blue Earth Diagnostics Ltd Synthesis of fluorosilyl compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR057023A1 (es) 2005-05-16 2007-11-14 Gilead Sciences Inc Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
PL2187965T3 (pl) 2007-08-17 2020-05-18 Purdue Research Foundation Koniugaty wiążący psma ligand-łącznik i sposoby ich zastosowania
EP3209336B1 (en) 2014-10-20 2019-12-11 Deutsches Krebsforschungszentrum 18f-tagged inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
US10800797B2 (en) 2015-05-26 2020-10-13 California Institute Of Technology Heteroaromatic silicon-fluoride-acceptors useful for 18F labeling of molecules and biomolecules, and methods of preparing same
HUE070098T2 (hu) 2017-07-28 2025-05-28 Univ Muenchen Tech Kettõs módusú radioaktív jelzõ és terapeutikumok

Similar Documents

Publication Publication Date Title
JP2022518598A5 (https=)
JP2954354B2 (ja) 造影用のテクネチウム‐99m標識ペプチド
KR0156541B1 (ko) 펩티드 유도체
JPWO2020145228A5 (https=)
CA2819850C (en) Psma-targeted dendrimers
RU2010140846A (ru) Конъюгаты антагониста пептида аналога бомбезина
JP3795521B2 (ja) ペプチド−キレート化剤複合体
JPH0421671B2 (https=)
JP2023129495A5 (https=)
KR100330794B1 (ko) 혈관질병진단제
AU2020257786B2 (en) Novel radiolabelled compounds for diagnosis or treatment of prostate-specific membrane antigen-expressing cancer
CA1340556C (en) High molecular compound comprising unit of asialoglyco-protein acceptor-directing compound and unit of chelate-forming compound chemically bonded thereto, and its utilization
IL295571A (en) Fibroblast activation protein ligands for targeted delivery applications
KR20130132935A (ko) Nota에 의해 복합체를 형성한 알루미늄―〔18〕플루오라이드로 표지된 her2 결합 펩티드
EP0977579A1 (en) Gastrin receptor-avid peptide conjugates
WO2013081091A1 (ja) 非特異的腎集積が低減された放射性標識ポリペプチド作製用薬剤
KR20130132939A (ko) 18f - 함유 유기실리콘 화합물로 표지된 her2 결합 펩티드
JP2025507971A (ja) 前立腺特異的膜抗原を標的とする放射性標識化合物
CN116981486A (zh) 双模式放射性示踪剂和治疗剂
CN115484992B (zh) 药物制剂
JP2001114792A (ja) ビスホスホン酸誘導体およびその放射性核種標識体
AU2022320317A1 (en) Radiolabeled compound and use thereof
FI104409B (fi) Kelaatinmuodostajia ja niitä sisältäviä, diagnostiikassa käytettäviä komplekseja
CN117945993A (zh) 一种含l-天冬氨酸连接体的谷氨酸-脲二聚体衍生物及其应用
RU2021125318A (ru) Радиофармацевтические препараты, замещенные фторидом кремния, и их предшественники